Device
Blephasteam
Blephasteam is a medical device with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
1
25%
Ph phase_4
3
75%
Phase Distribution
0
Early Stage
0
Mid Stage
3
Late Stage
Phase Distribution4 total trials
Phase 4Post-market surveillance
3(75.0%)
N/ANon-phased studies
1(25.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 43 (75.0%)
N/A1 (25.0%)
Trials by Status
completed4100%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_4
Optimization of the Treatment of Dry Eye Disease Caused by Meibomian Gland Dysfunction
NCT03318874
completednot_applicable
Eyelid Warming Technology for Meibomian Gland Dysfunction
NCT01448369
completedphase_4
Evaluation of Satisfaction Regarding Patient's Management of Ocular Surface Diseases
NCT01189474
completedphase_4
Evaluation of Satisfaction Regarding Patient's Management of Ocular Surface Diseases
NCT01091311
Clinical Trials (4)
Showing 4 of 4 trials
NCT03318874Phase 4
Optimization of the Treatment of Dry Eye Disease Caused by Meibomian Gland Dysfunction
NCT01448369Not Applicable
Eyelid Warming Technology for Meibomian Gland Dysfunction
NCT01189474Phase 4
Evaluation of Satisfaction Regarding Patient's Management of Ocular Surface Diseases
NCT01091311Phase 4
Evaluation of Satisfaction Regarding Patient's Management of Ocular Surface Diseases
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4